Description
The antibody is a Humanized IgG1-kappa-(Fab G1-kappa) with domain crossover targets Human APP & CD71/TFRC
Target
APP & CD71/TFRC
Target Alias Names
AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50, Transferrin receptor protein 1, TfR1, T9, Trfr, p90, CD71, TFRC, TfR, sTfR, TR
Isotype/Mimetic
IgG1-kappa-(Fab G1-kappa) with domain crossover
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
Unknown
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression